Anti Inflammatory Therapeutics Market
According to Intent Market Research, the Anti-Inflammatory Therapeutics Market is expected to grow from USD 111.4 billion in 2023 at a CAGR of 7.8% to touch USD 189.1 billion by 2030. The Anti-Inflammatory Therapeutics Market is dominated by key players such as Pfizer Inc., Johnson & Johnson, AbbVie Inc., Novartis International AG, Merck & Co., Inc., Bristol-Myers Squibb Company, Roche Holding AG, Sanofi S.A., Amgen Inc., Eli Lilly and Company, GlaxoSmithKline PLC, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences, Inc., Boehringer Ingelheim GmbH